Global Atherectomy Devices Market – Size, Share, Growth, Trends & Forecast 2025–2033

The Global Atherectomy Devices Market is poised for remarkable expansion, projected to grow from USD 1.05 billion in 2024 to reach USD 2.21 billion by 2033, registering a robust CAGR of 8.63% during the forecast period (2025–2033). This growth is primarily driven by the increasing prevalence of peripheral artery disease (PAD), technological advancements in device design, the aging global population, and the growing demand for minimally invasive procedures. Furthermore, improved reimbursement frameworks, particularly in emerging economies, are contributing significantly to market momentum.

Want pricing & detailed TOC? Enter your email:https://www.renub.com/request-sample-page.php?gturl=atherectomy-devices-market-p.php

Market Overview

Atherectomy devices are specialized medical tools used to remove atherosclerotic plaque from blood vessels. These devices are critical for treating vascular diseases such as coronary artery disease (CAD) and PAD, especially in patients who are poor candidates for balloon angioplasty or stenting. The various modalities—directional, rotational, orbital, and laser atherectomy—provide physicians with multiple options tailored to patient-specific needs.

The shift toward minimally invasive interventions, fueled by improved clinical outcomes and shorter recovery times, continues to expand the market potential of atherectomy devices globally.

Key Growth Drivers

1. Rising Prevalence of Peripheral Artery Disease (PAD)

PAD is becoming increasingly common due to rising incidences of diabetes, obesity, and hypertension, particularly among the elderly. Over 8–12 million Americans suffer from PAD, with global prevalence growing rapidly. Atherectomy devices provide a crucial treatment pathway for restoring arterial blood flow and preventing limb ischemia in PAD patients.

2. Technological Advancements

The market has witnessed significant innovations in device design, including:

• Improved plaque removal precision
• Lower vessel trauma
• Enhanced operator control and ergonomics
• Integration with imaging tools like OCT and IVUS for real-time guidance

These innovations have improved procedural efficiency and reduced complication rates. For instance, AngioDynamics' Auryon Atherectomy System, which received FDA 510(k) clearance in August 2022, showcases the advancement in laser-based technology for arterial thrombectomy.

3. Expansion into Emerging Markets

Healthcare investments in Asia-Pacific, Latin America, and the Middle East are rising, creating favorable conditions for market penetration. Factors such as:

• Rising disposable income
• Improved healthcare access
• Increasing government support
  are enabling wider adoption of atherectomy devices in these high-potential regions.

Market Challenges

1. Shortage of Skilled Operators

Despite the benefits, the deployment of atherectomy devices requires advanced operator skill and precision. A shortage of trained interventional cardiologists and vascular surgeons, particularly in developing regions, is a significant barrier to widespread adoption.

2. High Procedural and Device Costs

The high cost of atherectomy procedures, including both device procurement and associated hospital charges, poses a significant challenge, especially in low-income countries where reimbursement systems are underdeveloped. Cost remains a limiting factor despite the procedure’s clinical effectiveness.

Regional Market Insights

North America – Leading the Global Landscape

The United States dominates the global market due to its well-established healthcare infrastructure, strong prevalence of cardiovascular diseases, and high adoption of advanced treatment modalities. With over 55.8 million elderly Americans (16.8% of the population as of May 2023), the demand for PAD-related therapies is surging.

The prevalence of chronic diseases like diabetes and hyperlipidemia—key contributors to atherosclerosis—further propels demand for atherectomy devices. The CDC reports over 25 million Americans with high cholesterol, reinforcing the growing clinical need.

Europe – Emphasis on Technological Integration

Countries like Germany, France, and the United Kingdom are actively embracing atherectomy procedures due to increased awareness of minimally invasive options and favorable reimbursement landscapes. Germany, in particular, is a high-growth market with a focus on elderly care and advanced vascular procedures.

Asia-Pacific – Fastest Growing Market

Markets such as India, China, and Japan are witnessing rapid growth due to rising patient awareness, lifestyle diseases, and expanding healthcare investments. In India, a rising elderly population and increasing PAD prevalence are driving demand, supported by government-led health initiatives and improved healthcare access.

Middle East and Africa – A Rising Frontier

Countries like Saudi Arabia and the UAE are investing heavily in healthcare infrastructure. The rising incidence of lifestyle-related cardiovascular diseases, coupled with improved awareness and adoption of new medical technologies, is pushing the growth trajectory upward.

Segmentation Analysis

By Product Type

• Directional Atherectomy
• Rotational Atherectomy
• Orbital Atherectomy
• Laser Atherectomy

By Application

• Cardiovascular
• Neurovascular
• Peripheral Vascular

By End User

• Hospitals
• Ambulatory Care Services
• Medical Research Institutes

Regional Coverage

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Spain, Italy, Netherlands, etc.)
• Asia Pacific (China, Japan, India, South Korea, Australia, etc.)
• Latin America (Brazil, Mexico, Argentina)
• Middle East & Africa (Saudi Arabia, UAE, South Africa, Rest of MEA)

New Publish Blogs:

Top United States In Vitro Diagnostics Companies Driving Innovation in 2025

Top Limestone Companies Dominating the Global Market

Top Salmon Fish Companies Driving Global Aquaculture

Competitive Landscape: Key Players

The global atherectomy devices market is moderately consolidated, with leading companies focusing on R&D, regulatory approvals, and strategic collaborations to expand their market presence.

Conclusion

The Global Atherectomy Devices Market is entering a phase of transformative growth driven by clinical need, device innovation, and expanding global healthcare infrastructure. Although challenges like high cost and operator training persist, the long-term outlook remains promising due to rising cardiovascular disease prevalence and growing acceptance of minimally invasive therapies worldwide.

About Renub Research

Renub Research is a leading market research and consulting company offering management consulting and in-depth industry analysis across various sectors. With a global perspective and a local understanding, Renub Research delivers insights that matter.

About the Company:

Renub Research is a Market Research and Consulting Company. We have more than 15 years of experience especially in international Business-to-Business Researches, Surveys and Consulting. We provide a wide range of business research solutions that helps companies in making better business decisions. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses. Our wide clientele comprises major players in Healthcare, Travel and Tourism, Food Beverages, Power Energy, Information Technology, Telecom Internet, Chemical, Logistics Automotive, Consumer Goods Retail, Building, and Construction, Agriculture. Our core team is comprised of experienced people holding graduate, postgraduate, and Ph.D. degrees in Finance, Marketing, Human Resource, Bio-Technology, Medicine, Information Technology, Environmental Science, and many more.

Media Contact:

Company Name: Renub Research

Contact Person: Rajat Gupta, Marketing Manager

Phone No: +91-120-421-9822 (IND) | +1-478-202-3244 (USA)

Email: mailto:rajat@renub.com